Sign Up Today and Learn More About Apnimed Stock
Invest in or calculate the value of your shares in Apnimed or other pre-IPO companies through EquityZen's platform.
Apnimed Stock (APNI)
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
About Apnimed Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Health Care
Apnimed Press Mentions
Stay in the know about the latest news on Apnimed
Apnimed Announces Multiple Presentations at the American Thoracic Society (ATS) International Conference 2025 Highlighting Novel Techniques and Unmet Medical Needs in Sleep Medicine
prnewswire • May 06, 2025
Methods and compositions for treating sleep apnea
patents • May 04, 2025
Methods and compositions for treating sleep apnea
patents • May 04, 2025
Apnimed to Participate in the 24th Annual Needham Virtual Healthcare Conference
prnewswire • Mar 26, 2025
Apnimed to Host Virtual Investor Event Highlighting the Potential for AD109 as a Novel Pharmacotherapy for Obstructive Sleep Apnea on April 11, 2025
prnewswire • Mar 26, 2025
Apnimed Management
Leadership team at Apnimed
Founder, CEO & Board Chair
Lawrence G. Miller
Co-Founder and Medical Director
Luigi Taranto Montemurro
Join now and verify your accreditation status to gain access to:
- Apnimed Current Valuation
- Apnimed Stock Price
- Apnimed Management
- Available deals in Apnimed and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Apnimed Cap Table and Funding History by Share Class and Liquidity Preferences
- Apnimed Revenue and Financials
- Apnimed Highlights
- Apnimed Business Model
- Apnimed Risk Factors
- Apnimed Research Report from SACRA Research
Trading Apnimed Stock
How to invest in Apnimed stock?
Accredited investors can buy pre-IPO stock in companies like Apnimed through EquityZen funds. These investments are made available by existing Apnimed shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Apnimed stock?
Shareholders can sell their Apnimed stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
